Education
About Us
Working with TipRanks
Follow Us
Ultralife (ULBI)
:ULBI
ULBI Stock Chart & Stats
$5.80
-$0.26(-3.42%)
At close: 4:00 PM EST
$5.80
-$0.26(-3.42%)
Day’s Range― - ―
52-Week Range$4.07 - $9.52
Previous CloseN/A
Volume13.19K
Average Volume (3M)48.89K
Market Cap
$92.57M
Enterprise Value$158.24M
Total Cash (Recent Filing)$9.26M
Total Debt (Recent Filing)$53.80M
Price to Earnings (P/E)54.0
Beta1.65
Next Earnings
Jan 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding16,648,947
10 Day Avg. Volume60,683
30 Day Avg. Volume48,890
Financial Highlights & Ratios
PEG Ratio-1.43
Price to Book (P/B)0.92
Price to Sales (P/S)0.75
P/FCF Ratio8.39
Enterprise Value/Market Cap1.71
Enterprise Value/Revenue0.85
Enterprise Value/Gross Profit3.55
Enterprise Value/Ebitda13.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe nearly complete Electrochem integration is opening new markets for ULBI, including pipeline inspection, seismic telemetry, and sonobuoys.
Regulatory ApprovalFDA approval for ULBI's partner on the medical wearable opportunity is expected to lead to significant orders.
Sales PerformanceULBI's reported sales of $50.7M exceeded estimates, showing a 32% year-over-year increase.
Bears Say
Product Specific DemandA 12.3% decrease in medical battery sales partially offset ULBI's organic growth.
Ultralife News
ULBI FAQ
What was Ultralife’s price range in the past 12 months?
Ultralife lowest stock price was $4.07 and its highest was $9.52 in the past 12 months.
What is Ultralife’s market cap?
Ultralife’s market cap is $92.57M.
When is Ultralife’s upcoming earnings report date?
Ultralife’s upcoming earnings report date is Jan 29, 2026 which is in 57 days.
How were Ultralife’s earnings last quarter?
Ultralife released its earnings results on Nov 18, 2025. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of $0.21 by -$0.28.
Is Ultralife overvalued?
According to Wall Street analysts Ultralife’s price is currently Overvalued.
Does Ultralife pay dividends?
Ultralife does not currently pay dividends.
What is Ultralife’s EPS estimate?
Ultralife’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ultralife have?
Ultralife has 16,648,947 shares outstanding.
What happened to Ultralife’s price movement after its last earnings report?
Ultralife reported an EPS of -$0.07 in its last earnings report, missing expectations of $0.21. Following the earnings report the stock price went down -8.845%.
Which hedge fund is a major shareholder of Ultralife?
Currently, no hedge funds are holding shares in ULBI
Ultralife Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ULBI Sentiment 70%
Sector Average 68%
Sector Average 68%
Insider Transactions
Bought Shares
Worth $287.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.22%
12-Months-Change
Fundamentals
Return on Equity
1.26%
Trailing 12-Months
Asset Growth
28.88%
Trailing 12-Months
Company Description
Ultralife
Ultralife Corporation (ULBI) is a global provider of a diverse range of power and communications solutions, primarily serving the defense, medical, and industrial sectors. The company specializes in the design and manufacture of advanced battery systems, communication and power management systems, and a variety of accessories for portable power applications. With a strong focus on innovation and quality, Ultralife is committed to delivering reliable and sustainable power solutions to meet the demanding needs of its customers.
ULBI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance with revenue growth and a growing backlog as positive indicators, but challenges such as an operating loss, decreased gross margin, and increased operating expenses weigh on the results. The company is showing promise with new product developments and strategic initiatives to improve efficiency and integration.View all ULBI earnings summariesTechnical Analysis
CBAK Energy Technology
―
Espey Mfg & Electronics
―
Flux Power Holdings
―
SKYX Platforms
―
Dragonfly Energy Holdings Corp
―
Ownership Overview
38.99% Insiders
9.42% Mutual Funds
12.13% Other Institutional Investors
34.79% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---